Peptide Science, Research & Their Role in Longevity and Performance Medicine

What Are Peptides?

Peptides have become an increasingly discussed area of longevity, wellness and performance medicine, but they are not all the same.

Peptides are short chains of amino acids that can act as signaling molecules throughout the body. Naturally occurring peptides participate in many biological processes, including hormone signaling, metabolism, tissue repair, immune function and sexual function.

Some peptide-based medications have well-established medical uses and FDA approval. Others being discussed for recovery, body composition, metabolic health and healthy aging remain investigational or have limited human clinical data.

At RWell Center, our focus is not peptides—it is the patient.

Why Are Peptides Receiving So Much Attention?

Researchers have identified hundreds of naturally occurring peptides involved in human physiology. Because peptides can interact with specific receptors and signaling pathways, they have become an important area of pharmaceutical and medical research.

Depending on the specific peptide, research has explored potential roles involving:

Hormone Signaling • Metabolism • Body Composition • Sexual Health • Recovery & Tissue Repair • Immune Function • Cellular Health • Healthy Aging

Importantly, scientific interest does not necessarily mean proven clinical benefit. The amount and quality of evidence vary considerably from one peptide to another.

Peptides & the Recent FDA Changes

The FDA has recently increased its evaluation of peptide-related substances used in compounded medications, particularly substances that have not gone through the traditional FDA drug-approval process.

In July 2026, the FDA’s Pharmacy Compounding Advisory Committee reviewed several substances that have received significant attention in longevity and performance medicine, including BPC-157, KPV, TB-500 and MOTS-C. The meeting also considered DSIP/emideltide, Semax and Epitalon. These reviews concern whether specific bulk drug substances should be included on the federal 503A Bulks List for compounding.

What does this mean for patients?

It does not mean that all peptides have been banned, nor does it mean that all peptides are FDA-approved.

Instead, the FDA evaluates individual substances and the circumstances under which they may be compounded. Federal law places limits on which bulk drug substances can be used by traditional compounding pharmacies and outsourcing facilities.

The FDA has also raised concerns about certain compounded peptides related to limited human safety information, impurities, peptide aggregation and potential immune reactions.

It is also important to understand that compounded medications are not FDA-approved medications. FDA does not review compounded drugs for safety, effectiveness and quality before they are marketed in the same way it reviews an FDA-approved drug.

The important question is not simply, “Is it a peptide?” It is: What is the specific compound, what evidence supports it, what is its FDA and regulatory status, and is it appropriate for the individual patient?

Because the FDA’s evaluation of some of these substances is ongoing, their regulatory status may continue to evolve. FDA stated that the July advisory-committee process preceded its final determinations.

Commonly Discussed Peptides

There are many different peptides, and they should not be grouped together as though they have identical effects, evidence or regulatory status.

BPC-157
A synthetic peptide that has attracted attention for tissue repair and gastrointestinal research. Much of the interest is based on preclinical research, and it is not an FDA-approved drug.

TB-500 / Thymosin-Related Peptides
Compounds discussed primarily in relation to tissue repair, recovery and wound-healing research. Regulatory status and evidence should be distinguished from naturally occurring thymosin peptides.

CJC-1295 & Ipamorelin
Peptides discussed for their effects on the growth hormone signaling pathway. They have attracted interest in body composition, recovery and performance settings, but regulatory and safety considerations differ between compounds.

Sermorelin
A growth hormone-releasing hormone analog that stimulates the body’s signaling for growth hormone production. Its history and regulatory status differ from many of the newer peptides promoted online.

Tesamorelin
An example of why peptides should not all be classified together. Tesamorelin is an FDA-approved peptide-based medication for a specific medical indication, although that does not mean it is approved for general longevity, weight loss or performance enhancement.

Bremelanotide / PT-141
Another example of an FDA-approved peptide-based drug. Bremelanotide is approved for a specific sexual-health indication in certain premenopausal women, rather than as a general sexual-enhancement or longevity medication.

MOTS-C
A mitochondrial-derived peptide being studied for its potential relationship to metabolism, cellular signaling and aging biology. Much of the current interest remains research-based.

GHK-Cu
A naturally occurring copper-binding peptide investigated in areas including skin biology and tissue repair. Evidence and regulatory considerations depend in part on formulation and route of administration.

Thymosin Alpha-1
A peptide studied for its effects on immune signaling and immune regulation. Its regulatory status varies internationally and by intended use.

Kisspeptin
A naturally occurring peptide involved in the hypothalamic-pituitary-gonadal axis and reproductive hormone signaling. It has been studied in reproductive and hormonal medicine.

FDA-Approved Peptides vs. Investigational Peptides

The word “peptide” describes a type of molecule—not a regulatory category.

There are FDA-approved peptide-based medications used throughout medicine. At the same time, many peptides promoted online for longevity, recovery or performance have not been FDA-approved for those purposes.

There is also an important distinction between an FDA-approved medication, an appropriately compounded medication, and an investigational or unapproved substance.

That distinction is particularly important as peptide science continues to evolve.

Peptides & Life and Performance

The scientific interest surrounding peptides overlaps with many areas considered within the broader RWell Center approach, including:

Hormonal Health • Sexual Health • Metabolic Health • Body Composition • Recovery • Immune Health • Cellular Health • Healthy Aging

However, no single peptide should be viewed as a shortcut to longevity or optimal health.

Sleep, nutrition, exercise, cardiovascular and metabolic health, hormone balance, body composition and appropriate medical evaluation remain fundamental.

Test. Understand. Personalize. Monitor.

The RWell Center Perspective

RWell Center approaches emerging areas of medicine with interest, but also appropriate medical caution. Our approach places peptide science within the broader context of hormonal health, sexual health, metabolic health, advanced health testing, nutrition, performance and healthy aging.

Peptide Education in Philadelphia, Manhattan & the Lehigh Valley

RWell Center provides physician-guided education about peptides, longevity medicine, hormone optimization and emerging areas of health and performance medicine for patients in Philadelphia and the Main Line, Manhattan and New York City, and the Lehigh Valley, including Allentown, Bethlehem and Easton.

Our approach places peptide science within the broader context of hormonal health, sexual health, metabolic health, advanced health testing, nutrition, performance and healthy aging.

About This Information
RWell Center provides information about peptides because they have become an important topic in conversations surrounding longevity, wellness and performance medicine. This information is provided for educational purposes and should not be interpreted as an endorsement, recommendation or offer of any particular peptide treatment.